Abstract
This synthesis of pyrazolo[4,3-b]pyridine-5-one derivatives, recently described as potent and selective agonists/inverse agonists of the cannabinoid type-2 receptor (CB2R), allows for a wider exploration of the structure-activity relationship.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have